<DOC>
	<DOCNO>NCT00566527</DOCNO>
	<brief_summary>- Primary objective : - To demonstrate 2-dose regimen ProQuad® rHA administer 3-month interval healthy child 11 month age time Dose 1 immunogenic healthy child 12 month age time Dose 1 . - To demonstrate 2-dose regimen ProQuad® rHA administer 3-month interval healthy child 9 month age time Dose 1 immunogenic healthy child 12 month age time Dose 1 . - To demonstrate 2-dose regimen ProQuad® rHA administer 3-month interval healthy child 11 month age 9 month age time Dose 1 well-tolerated compare child 12 month age time Dose 1 . - Secondary objective - To describe antibody titre measles , mumps , rubella varicella Day 42 follow Dose 1 Dose 2 ProQuad® rHA administer healthy child 9 month age . - To evaluate safety profile Dose 1 Dose 2 ProQuad® rHA administer healthy child 9 month age .</brief_summary>
	<brief_title>Comparative Study Immunogenicity Safety 2-dose Regimen ProQuad® Manufactured With rHA</brief_title>
	<detailed_description />
	<mesh_term>Rubella</mesh_term>
	<criteria>1 . Healthy subject either gender 9 month age 2 . Negative clinical history measles , mumps , rubella , varicella zoster 3 . Informed consent form sign parent legal representative 4 . Parent ( ) legal representative able attend schedule visit subject understand comply study procedures 1 . Febrile illness previous 3 day 2 . Prior vaccination measles , mumps , rubella and/or varicella vaccine either alone combination 3 . Exposure measles , mumps , rubella , varicella and/or zoster previous 30 day 4 . Tuberculin test do previous 2 day 5 . Severe chronic disease 6 . Known active tuberculosis 7 . Known personal history encephalopathy , seizure disorder progressive , evolve unstable neurological condition 8 . Hereditary problem fructose intolerance 9 . Prior known sensitivity allergy component vaccine 10 . Known blood dyscrasia , leukemia , lymphomas type , malignant neoplasm affect bone marrow lymphatic system 11 . Humoral cellular immunodeficiency , 12 . Immunosuppressive therapy high dos least 14 day previous 30 day 13 . Family history congenital hereditary immunodeficiency 14 . Receipt immunoglobulins bloodderived product previous 150 day 15 . Receipt inactivate vaccine previous 14 day 16 . Receipt live nonstudy vaccine previous 28 day</criteria>
	<gender>All</gender>
	<minimum_age>9 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>